Scientists Take a Giant Step Closer to Treating Obesity With a Pill

News   Apr 19, 2018 | Original Story from SIMMCAS

 
Neuropeptide Y Y1 Receptor Structure Solved, Offers New Opportunities for Anti-obesity Drug Discovery

Figure: The crystal structure of Y1R binding to an antagonist UR-MK299. The receptor is shown in blue cartoon and surface representations. The antagonist UR-MK299 is shown as grey spheres. Credit: Dr. WU Beili’s group from SIMMCAS

 
 
 

RELATED ARTICLES

New Inherited Neurodevelopmental Disease Discovered

News

Researchers have identified a new inherited neurodevelopmental disease that causes slow growth, seizures and learning difficulties in humans.

READ MORE

XenoGesis and BioAscent Forge Alliance to Offer Enhanced Integrated Drug Discovery Services

News

XenoGesis and BioAscent Discovery Limited have announced a collaboration to offer an enhanced range of integrated drug discovery services, including medicinal chemistry, biology and DMPK.

READ MORE

BioAscent Establishes Integrated Drug Discovery Services Offering

News

Dr Phil Jones to join as new CSO to lead company’s extended capabilities in medicinal chemistry and in vitro biosciences.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Drug Discovery Neuroscience

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE